CONSOLIDATED STATEMENTS OF INCOME (LOSS) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenues
Product sales	$ 1,994.1	$ 1,063.5	$ 3,845.2	$ 2,102.4
Other revenues	47.0	32.2	82.1	61.7
Total revenues	2,041.1	1,095.7	3,927.3	2,164.1
Expenses
Cost of goods sold (exclusive of amortization and impairments of finite-lived intangible assets shown separately below)	569.6	283.2	1,073.7	568.1
Cost of other revenues	16.0	14.5	30.3	29.9
Selling, general and administrative	515.7	257.3	997.7	499.2
Research and development	66.5	24.5	127.8	48.3
Amortization and impairments of finite-lived intangible assets (see Note 8)	365.6	303.6	720.8	629.8
Restructuring, integration and other costs	142.1	53.6	275.7	102.6
In-process research and development impairments and other charges	8.4	4.8	20.4	4.8
Acquisition-related costs	0.6	7.9	2.1	15.8
Acquisition-related contingent consideration	1.9	3.7	10.8	1.5
Other (income) expense	(0.4)	1.1	(43.7)	5.6
Total expenses	1,686.0	954.2	3,215.6	1,905.6
Operating income	355.1	141.5	711.7	258.5
Interest income	1.2	1.0	3.0	2.6
Interest expense	(241.2)	(176.8)	(487.7)	(332.1)
Loss on extinguishment of debt	0	0	(93.7)	(21.4)
Foreign exchange and other	3.4	(10.0)	(10.0)	(8.6)
Gain on investments, net	2.5	3.9	2.5	5.8
Income (loss) before (recovery of) provision for income taxes	121.0	(40.4)	125.8	(95.2)
(Recovery of) provision for income taxes	(1.0)	(51.2)	24.1	(78.5)
Net income (loss)	122.0	10.8	101.7	(16.7)
Less: Net loss attributable to noncontrolling interest	(3.8)	0	(1.5)	0
Net income (loss) attributable to Valeant Pharmaceuticals International, Inc.	$ 125.8	$ 10.8	$ 103.2	$ (16.7)
Earnings (loss) per share attributable to Valeant Pharmaceuticals International, Inc.:
Basic (in dollars per share)	$ 0.38	$ 0.04	$ 0.31	$ (0.05)
Diluted (in dollars per share)	$ 0.37	$ 0.03	$ 0.30	$ (0.05)
Weighted-average common shares
Basic (in shares)	335.3	308.1	335.1	307.7
Diluted (in shares)	341.3	314.4	341.4	307.7